PrEDICT: Clinical Decision Support for PrEP

Sponsor
Harvard Pilgrim Health Care (Other)
Overall Status
Recruiting
CT.gov ID
NCT05245201
Collaborator
OCHIN, Inc. (Other), Oregon Health and Science University (Other), National Institute of Mental Health (NIMH) (NIH), Beth Israel Deaconess Medical Center (Other)
4
3
2
21.7
1.3
0.1

Study Details

Study Description

Brief Summary

Scale-up of HIV preexposure prophylaxis (PrEP) is a key strategy of the federal initiative to end the HIV epidemic. However, healthcare providers lack tools to identify patients who are at increased risk for HIV infection and thus likely to benefit from PrEP. This pilot study will test the hypothesis that an electronic health record (EHR)-based clinical decision support system that incorporates an HIV risk prediction model can help providers identify patients at increased risk for HIV infection and improve PrEP prescribing in safety-net community health centers. The clinical decision support system will be implemented in the EHR at 2-3intervention clinics, while 2 control clinics will receive standard of care. The primary outcome is PrEP prescriptions. Other key metrics of PrEP-related care to be assessed include medication persistence, adherence to monitoring guidelines for PrEP, and rates of HIV/STI testing and diagnoses. The expected outcome is the foundation for a large-scale cluster randomized trial to test whether EHR-based clinical decision support tools for PrEP can improve PrEP prescribing and prevent new HIV infections in a national network of community health centers.

Condition or Disease Intervention/Treatment Phase
  • Other: Standard of care
  • Other: Clinical decision support for PrEP
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
4 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
The intervention will be implemented in 2-3 clinics, with 2-3 control clinics receiving standard of care. Eligible community health centers will be those with at least 500 patients and a minimum of 10 HIV diagnoses. Clinics located in counties identified as HIV hotspots will be prioritized. Clinics specializing in HIV or sexual health care, where providers may have less need for PrEP decision support, will be excluded. Overall, 26 clinics are expected to meet these eligibility criteria, with a total of 831 incident HIV diagnoses in 2018. Of eligible clinics, 2-3 will be recruited to receive the intervention. Using a covariate-constrained matching procedure with EHR data on important covariates (e.g., urbanity and the sex, race, and age distributions of the patient population), 2-3matched control clinics will be selected.The intervention will be implemented in 2-3 clinics, with 2-3 control clinics receiving standard of care. Eligible community health centers will be those with at least 500 patients and a minimum of 10 HIV diagnoses. Clinics located in counties identified as HIV hotspots will be prioritized. Clinics specializing in HIV or sexual health care, where providers may have less need for PrEP decision support, will be excluded. Overall, 26 clinics are expected to meet these eligibility criteria, with a total of 831 incident HIV diagnoses in 2018. Of eligible clinics, 2-3 will be recruited to receive the intervention. Using a covariate-constrained matching procedure with EHR data on important covariates (e.g., urbanity and the sex, race, and age distributions of the patient population), 2-3matched control clinics will be selected.
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Optimizing EHR-Based Prediction Models to Improve HIV Preexposure Prophylaxis Use in Community Health Centers
Actual Study Start Date :
Jul 11, 2022
Anticipated Primary Completion Date :
Feb 1, 2024
Anticipated Study Completion Date :
May 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Arm 1 - Standard of care

Standard of care

Other: Standard of care
Two control clinics will be selected based on a set of matching criteria, e.g., urbanity and the sex, race, and age distributions of the patient population. Control clinics will not participate in study activities.

Active Comparator: Arm 2 - Clinical decision support for PrEP

EHR-based decision support tools to support PrEP discussions and prescribing for patients who have increased predicted HIV risk

Other: Clinical decision support for PrEP
Healthcare providers at 2 intervention clinics (total of approximately 60 providers anticipated) will be prompted by an EHR-based tool to discuss PrEP with patients whose demographics and clinical history indicate increased predicted HIV risk. Providers will be offered clinical decision support tools to guide sexual health discussions and support PrEP prescribing.

Outcome Measures

Primary Outcome Measures

  1. PrEP prescriptions [9 months]

    Number of patients with increased predicted HIV risk who are prescribed PrEP

Secondary Outcome Measures

  1. Feasibility of clinical decision support system [6 months]

    Rates at which providers view alerts about patients with increased predicted HIV risk and rates at which providers access the EHR-based decision support tools using Epic date-time stamps

  2. Acceptability of clinical decision support system [6 months]

    One-on-one feedback interviews with clinic administrators and 3-5 providers at intervention clinics

Eligibility Criteria

Criteria

Ages Eligible for Study:
15 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Primary care providers at participating clinics who are licensed to prescribe PrEP
Exclusion Criteria:
  • N/A

Contacts and Locations

Locations

Site City State Country Postal Code
1 Saban Community Clinic Los Angeles California United States 90038
2 Roanoke Chowan Community Health Center Ahoskie North Carolina United States 27910
3 Kintegra Health Gastonia North Carolina United States 28052

Sponsors and Collaborators

  • Harvard Pilgrim Health Care
  • OCHIN, Inc.
  • Oregon Health and Science University
  • National Institute of Mental Health (NIMH)
  • Beth Israel Deaconess Medical Center

Investigators

  • Principal Investigator: Julia Marcus, PhD, Harvard Pilgrim Health Care Institute
  • Principal Investigator: Douglas Krakower, MD, Beth Israel Deaconess Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Harvard Pilgrim Health Care
ClinicalTrials.gov Identifier:
NCT05245201
Other Study ID Numbers:
  • PH000739A
  • R34MH122291
First Posted:
Feb 17, 2022
Last Update Posted:
Aug 3, 2022
Last Verified:
Aug 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Harvard Pilgrim Health Care
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 3, 2022